Health Tidings Policy & AcquisitionsBeam Therapeutics Advances BEAM-304 for PKU and Pfizer Collaboration Beam Therapeutics Advances BEAM-304 for PKU and Pfizer Collaboration Read Post »
Health Tidings Policy & AcquisitionsNovo Nordisk Partners with Vivtex to Pioneer Oral Biologics for Obesity and... Novo Nordisk Partners with Vivtex to Pioneer Oral Biologics for Obesity and... Read Post »
Health Tidings Policy & AcquisitionsGSK Acquires 35Pharma for $950M to Advance HS235 in Pulmonary Hypertension ... GSK Acquires 35Pharma for $950M to Advance HS235 in Pulmonary Hypertension ... Read Post »
Health TidingsViatris Phentolamine Drops Advance to FDA Review for Presbyopia Treatment Viatris Phentolamine Drops Advance to FDA Review for Presbyopia Treatment Read Post »
Health TidingsOno Expands Opdivo® Reach: New Korean Approval for MSI-High CRC Ono Expands Opdivo® Reach: New Korean Approval for MSI-High CRC Read Post »
Health Tidings Policy & AcquisitionsAstellas and Vir Biotechnology Unite to Advance VIR-5500, a Next-Gen T-Cell... Astellas and Vir Biotechnology Unite to Advance VIR-5500, a Next-Gen T-Cell... Read Post »
Health TidingsTeva/Medincell Advance: SOLARIS-Backed TEV-‘749 NDA Accepted by FDA Teva/Medincell Advance: SOLARIS-Backed TEV-‘749 NDA Accepted by FDA Read Post »
Health TidingsNovo Nordisk Slashes List Prices of Wegovy, Ozempic, and Rybelsus by Up to ... Novo Nordisk Slashes List Prices of Wegovy, Ozempic, and Rybelsus by Up to ... Read Post »
Health Tidings Policy & AcquisitionsOrganon Licenses MIUDELLA®: New Hormone-Free Copper IUD Option Organon Licenses MIUDELLA®: New Hormone-Free Copper IUD Option Read Post »
Health TidingsFlexible SC Amivantamab Regimens Now Authorized EU-Wide for EGFR-Mutant Lun... Flexible SC Amivantamab Regimens Now Authorized EU-Wide for EGFR-Mutant Lun... Read Post »
Health TidingsUltragenyx Scores FDA Priority Review for DTX401 in Rare Metabolic Disorder Ultragenyx Scores FDA Priority Review for DTX401 in Rare Metabolic Disorder Read Post »
Health TidingsEMA Validates ENHERTU® for Post-Neoadjuvant HER2+ Breast Cancer EMA Validates ENHERTU® for Post-Neoadjuvant HER2+ Breast Cancer Read Post »
Health TidingsSetback for Corcept as Court Backs Teva in Korlym Generic Fight Setback for Corcept as Court Backs Teva in Korlym Generic Fight Read Post »
Health TidingsRoche’s Giredestrant NDA Accepted by FDA for ESR1-Mutated Breast Canc... Roche’s Giredestrant NDA Accepted by FDA for ESR1-Mutated Breast Canc... Read Post »
Health TidingsSavara’s MOLBREEVI BLA Accepted by FDA with Priority Review for Rare ... Savara’s MOLBREEVI BLA Accepted by FDA with Priority Review for Rare ... Read Post »
Health TidingsOne High-Quality Trial, Not Two: what the FDA changed and what it means One High-Quality Trial, Not Two: what the FDA changed and what it means Read Post »
Health TidingsOutlook Therapeutics Partners with Mediconsult for Exclusive LYTENAVA™ Di... Outlook Therapeutics Partners with Mediconsult for Exclusive LYTENAVA™ Di... Read Post »
Health TidingsChugai Launches ELEVIDYS in Japan for Duchenne Muscular Dystrophy Chugai Launches ELEVIDYS in Japan for Duchenne Muscular Dystrophy Read Post »
Health TidingsRYBREVANT FASPRO™ Shines in First-Line HNSCC with 56% Response Rate RYBREVANT FASPRO™ Shines in First-Line HNSCC with 56% Response Rate Read Post »
Health TidingsOmvoh Sets New IBD Standard: 3-Year Data + Lilly’s Combination Pipeli... Omvoh Sets New IBD Standard: 3-Year Data + Lilly’s Combination Pipeli... Read Post »
Health TidingsBoehringer Ingelheim Teams Up with NIPER Raebareli for Pharma Research Boos... Boehringer Ingelheim Teams Up with NIPER Raebareli for Pharma Research Boos... Read Post »
Health TidingsFDA Grants Priority Review to Garetosmab for Rare Bone Disorder FOP FDA Grants Priority Review to Garetosmab for Rare Bone Disorder FOP Read Post »
Health Tidings Policy & AcquisitionsNovartis Licenses UNP’s Macrocyclic Peptides in $1.8B CVD Collaborati... Novartis Licenses UNP’s Macrocyclic Peptides in $1.8B CVD Collaborati... Read Post »
Health TidingsJanux Therapeutics Dosed First Patient in JANX011 Study Janux Therapeutics Dosed First Patient in JANX011 Study Read Post »
Health TidingsRTF Resolved: Moderna’s Vaccine mRNA-1010 Advances to FDA Review RTF Resolved: Moderna’s Vaccine mRNA-1010 Advances to FDA Review Read Post »
Health TidingsFDA Accepts BMS’s NDA for Iberdomide in RRMM FDA Accepts BMS’s NDA for Iberdomide in RRMM Read Post »
Health TidingsEli Lilly’s TOGETHER-PsO Trial: Taltz Plus Zepbound Delivers Superior... Eli Lilly’s TOGETHER-PsO Trial: Taltz Plus Zepbound Delivers Superior... Read Post »
Health TidingsCompass Pathways Achieves Breakthrough in Phase 3 Trial for Psilocybin-Base... Compass Pathways Achieves Breakthrough in Phase 3 Trial for Psilocybin-Base... Read Post »
Health TidingsGSK RSV Vaccine Shows 75.6% Effectiveness Against Hospitalizations in Real-... GSK RSV Vaccine Shows 75.6% Effectiveness Against Hospitalizations in Real-... Read Post »
Health Tidings Policy & AcquisitionsKidswell Bio and Treehill Launch Kidswell USA to Advance Cell Therapy for C... Kidswell Bio and Treehill Launch Kidswell USA to Advance Cell Therapy for C... Read Post »
Health TidingsOno Pharmaceutical’s Tirabrutinib NDA Accepted by FDA for R/R PCNSL Ono Pharmaceutical’s Tirabrutinib NDA Accepted by FDA for R/R PCNSL Read Post »
Health TidingsLilly’s Retevmo Improves Event-Free Survival in Early RET+ NSCLC Lilly’s Retevmo Improves Event-Free Survival in Early RET+ NSCLC Read Post »
Health TidingsNeedle-Free neffy: Launches in Australia for Anaphylaxis Needle-Free neffy: Launches in Australia for Anaphylaxis Read Post »
Health TidingsEisai Secures Orphan Drug Designation in Japan for E2086 in Narcolepsy Eisai Secures Orphan Drug Designation in Japan for E2086 in Narcolepsy Read Post »
Health TidingsOtsuka’s REXULTI Added to Japan’s Disaster Essential Medicines List Otsuka’s REXULTI Added to Japan’s Disaster Essential Medicines List Read Post »
Health TidingsDisc Medicine Gets FDA CRL for Bitopertin, Eyes APOLLO Trial Disc Medicine Gets FDA CRL for Bitopertin, Eyes APOLLO Trial Read Post »
Health TidingsPTC Pulls Ataluren NDA for nmDMD After FDA Review Feedback PTC Pulls Ataluren NDA for nmDMD After FDA Review Feedback Read Post »
Health TidingsINmune Bio Files MHRA Pre-Submission for CORDStrom in RDEB INmune Bio Files MHRA Pre-Submission for CORDStrom in RDEB Read Post »
Health TidingsNovo Nordisk Targets Access and Flexibility with Planned Wegovy Vials Novo Nordisk Targets Access and Flexibility with Planned Wegovy Vials Read Post »
Health TidingsOutlook Therapeutics Seeks FDA Type A Meeting Following CRL for LYTENAVA™... Outlook Therapeutics Seeks FDA Type A Meeting Following CRL for LYTENAVA™... Read Post »
Health TidingsREGENXBIO Unveils 2026 Pipeline Catalysts with Strong 18-Month DMD Trial Da... REGENXBIO Unveils 2026 Pipeline Catalysts with Strong 18-Month DMD Trial Da... Read Post »
Health TidingsDewpoint MYC Condensate Modulator Hits DC Stage Dewpoint MYC Condensate Modulator Hits DC Stage Read Post »
Health TidingsAstellas Secures $210 Million in Settlements with Lupin and Zydus Over Myrb... Astellas Secures $210 Million in Settlements with Lupin and Zydus Over Myrb... Read Post »
Health Tidings Policy & AcquisitionsSanofi Closes Dynavax Deal, Expands Presence in Adult Vaccines Sanofi Closes Dynavax Deal, Expands Presence in Adult Vaccines Read Post »
Health Tidings Policy & AcquisitionsChugai Licenses Araris’ AraLinQ® Platform to Advance Next-Generation ADC... Chugai Licenses Araris’ AraLinQ® Platform to Advance Next-Generation ADC... Read Post »
Health TidingsFDA Issues Refusal-to-File Letter for Moderna’s mRNA-1010 Flu Vaccine FDA Issues Refusal-to-File Letter for Moderna’s mRNA-1010 Flu Vaccine Read Post »
Food Health TidingsFDA Initiates Priority Safety Review of BHA Used in Foods FDA Initiates Priority Safety Review of BHA Used in Foods Read Post »
Health TidingsIambic, Takeda Team Up on AI-Driven Small Molecule Discovery Iambic, Takeda Team Up on AI-Driven Small Molecule Discovery Read Post »
Health TidingsAstellas Pharma Inc. Settles U.S. Patent Litigation with Lupin Limited Over... Astellas Pharma Inc. Settles U.S. Patent Litigation with Lupin Limited Over... Read Post »
Health TidingsFDA Issues CRL for REGENXBIO’s RGX-121 in MPS II FDA Issues CRL for REGENXBIO’s RGX-121 in MPS II Read Post »
